Genome&Company - ESG Rating & Company Profile powered by AI
Complete ESG assessment of Genome&Company can be accessed by signing up for free. This webpage of Genome&Company was prepared by All Street Sevva using cutting edge AI. If you are employed by Genome&Company and you would like to licence your Sustainability aseessment, please contact us.
Genome&Company in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 1.2; made up of an environmental score of 2.0, social score of 1.6 and governance score of 0.0.
1.2
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1755 | TRACON Pharmaceuticals Inc | 1.3 | Low |
1755 | Trimurthi Ltd | 1.3 | Low |
1779 | Genome&Company | 1.2 | Low |
1779 | Cell Biotech Co Ltd | 1.2 | Low |
1779 | Aurisco Pharmaceutical Co Ltd | 1.2 | Low |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does Genome&Company have an accelerator or VC vehicle to help deliver innovation?
Does Genome&Company disclose current and historical energy intensity?
Does Genome&Company report the average age of the workforce?
Does Genome&Company reference operational or capital allocation in relation to climate change?
Does Genome&Company disclose its ethnicity pay gap?
Does Genome&Company disclose cybersecurity risks?
Does Genome&Company use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does Genome&Company offer flexible work?
Does Genome&Company have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Genome&Company disclose the number of employees in R&D functions?
Does Genome&Company plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does Genome&Company conduct supply chain audits?
Does Genome&Company disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Genome&Company conduct 360 degree staff reviews?
Does Genome&Company disclose the individual responsible for D&I?
Does Genome&Company disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Genome&Company disclose current and / or historical scope 2 emissions?
Does Genome&Company disclose water use targets?
Does Genome&Company have careers partnerships with academic institutions?
Did Genome&Company have a product recall in the last two years?
Does Genome&Company disclose incidents of discrimination?
Does Genome&Company allow for Work Councils/Collective Agreements to be formed?
Has Genome&Company issued a profit warning in the past 24 months?
Does Genome&Company disclose parental leave metrics?
Does Genome&Company disclose climate scenario or pathway analysis?
Does Genome&Company disclose current and / or historical scope 1 emissions?
Does Genome&Company explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does Genome&Company disclose the pay ratio of women to men?
Does Genome&Company support suppliers with sustainability related research and development?
Does Genome&Company disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Genome&Company reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Genome&Company involved in embryonic stem cell research?
Does Genome&Company disclose GHG and Air Emissions intensity?
Does Genome&Company disclose its waste policy?
Does Genome&Company report according to TCFD requirements?
Does Genome&Company plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does Genome&Company disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Genome&Company disclose energy use targets?
Does Genome&Company disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does Genome&Company have a policy relating to cyber security?
Have a different question?
Potential Risks for Genome&Company
These potential risks are based on the size, segment and geographies of the company.